UDC

616.12-009.86(98)

DOI

10.37482/2687-1491-Z057

Authors

Nadezda A. Vorob’eva*/** ORCID: 0000-0001-6613-2485
Alena I. Vorob’eva* ORCID: 0000-0003-4817-6884
Anastasiya A. Marusiy* ORCID: 0000-0002-7908-0183

 *Northern State Medical University (Arkhangelsk, Russian Federation)
**Northern Branch of the National Medical Research Centre for Haematology (Arkhangelsk, Russian Federation)

Corresponding author: Nadezda Vorob’eva, address: prosp. Troitskiy 51, Arkhangelsk, 163001, Russian Federation; e-mail: nadejdav0@gmail.com

Abstract

Among other areas of research, clinical medicine studies the adaptation mechanisms of the vascular endothelium to the extreme conditions of the Arctic. This paper dwells on the possible relationship of the development of endothelial dysfunction and the antioxidant system with modifiable risk factors during a short translatitudinal voyage in the Arctic. The study involved 32 crew members of the research vessel Mikhail Somov during the TransArctic–2019 research expedition. Venous blood sampling was carried out before the voyage at the zero point (Arkhangelsk, 64°33’N 40°32’E) and at the highest point of the expedition (Hayes Island, 80°34’N 57°41’E). Endothelin-1 concentration and serum total antioxidant capacity were determined using the enzyme-linked immunosorbent assay. We found statistically significant differences (Student’s t-test: t = –3.6532; df = 31; p < 0.001) in endothelin-1 concentration at the zero point (4.79 ± 2.10 pg/ml) and high point (7.02 ± 2.42 pg/ml), which indicates vasoconstriction, i.e. the first signs of the formation of vascular endothelium maladaptation. In 84.4 % of the crew members at the high point we detected high total antioxidant capacity, which can indicate compensation of antioxidant defence mechanisms. Noteworthy, serum total antioxidant capacity in smokers was statistically significantly higher than in non-smokers. Moreover, the predominance of high antioxidant activity among the crew members points to an increased oxidative load on the sailors’ body having to neutralize the excess amount of reactive oxygen species.
For citation: Vorob’eva N.A., Vorob’eva A.I., Marusiy A.A. Risk of Endothelial Dysfunction and Total Antioxidant Capacity in Seafarers During an Arctic Voyage. Journal of Medical and Biological Research, 2021, vol. 9, no. 2, pp. 192–200. DOI: 10.37482/2687-1491-Z057

Keywords

marine medicine, endothelial dysfunction, endothelin-1, total antioxidant capacity, translatitudinal voyage, Arctic

References

1. Strategy for the Development of the Arctic Zone of the Russian Federation and Ensuring National Security for the Period Until 2020: Decree of the President of the Russian Federation No. 232, Dated 20 February 2013. Accessed from Consultant Plus Assistance System (in Russ.).
2. Evdokimov V.I. Tsirkumpolyarnaya meditsina: metaanaliz otechestvennykh nauchnykh statey (2005– 2018 gg.) [Circumpolar Medicine: A Meta-Analysis of Russian Scientific Articles (2005–2018)]. St. Petersburg, 2019. 267 p.
3. Sinenko P.V. Osobennosti sotsial’no-ekonomicheskogo razvitiya rayonov Kraynego Severa i Arkticheskoy zony Rossiyskoy Federatsii [Features of the Socio-Economic Development of the Far North and the Arctic Zone of the Russian Federation]. Ekonomika: vchera, segodnya, zavtra, 2016, no. 12, pp. 18–25.
4. Deputat I.S., Deryabina I.N., Nekhoroshkova A.N., Gribanov A.V. Effect of Climatic and Ecological Conditions of the North on Ageing Processes. J. Med. Biol. Res., 2017, vol. 5, no. 3, pp. 5–17. DOI: 10.17238/issn2542-1298.2017.5.3.5
5. Solonin Yu.G., Boyko E.R. Mediko-fiziologicheskie problemy v Arktike [Medical and Physiological Problems of the Arctic]. Izvestiya Komi nauchnogo tsentra Ural’skogo otdeleniya RAN, 2017, no. 4, pp. 33–40.
6. Krivoshchekov S.G., Okhotnikov S.V. Proizvodstvennye migratsii i zdorov’e cheloveka na Severe [Work Migration and Human Health in the North]. Novosibirsk, 2000. 1 18 p.
7. Rossiyskiy statisticheskiy ezhegodnik. 2018 [Russian Statistical Yearbook. 2018]. Moscow, 2018. 694 p.
8. Population Mortality Data by Causes of Death in the Russian Federation for January – December 2019. Available at: https://www.gks.ru/free_doc/2019/demo/edn12-19.htm (accessed: 15 April 2021) (in Russ.).
9. V’yunitskaya L.V. Markery disfunktsii endoteliya [Endothelial Dysfunction Markers]. Laboratornaya diagnostika. Vostochnaya Evropa, 2015, no. 3-4, pp. 37–51.
10. Zinchuk V.V., Glebov A.N. NO-zavisimye mekhanizmy formirovaniya kislorodsvyazyvayushchikh svoystv krovi pri okislitel’nom stresse [NO-Dependent Mechanisms of Blood Oxygen-Binding Properties Formation in Oxidative Stress]. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta, 2007, no. 1,
pp. 139–142.
11. Khasnulin V.I., Khasnulin P.V. Sovremennye predstavleniya o mekhanizmakh formirovaniya severnogo stressa u cheloveka v vysokikh shirotakh [Modern Concepts of the Mechanisms Forming Northern Stress in Humans in High Latitudes]. Ekologiya cheloveka, 2012, no. 1, pp. 3–11.
12. Aird W.C. Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms. Circ. Res., 2007, vol. 100, no. 2, pp. 158–173. DOI: 10.1161/01.RES.0000255691.76142.4a
13. Shurygin M.G., Shurygina I.A., Kanya O.V., Dremina N.N., Lushnikova E.L., Nepomnyashchikh L.M. Znachenie povysheniya produktsii endotelina pri infarkte miokarda [Significance of the Increased Production of Endothelin in Myocardial Infarction]. Fundamental’nye issledovaniya, 2015, no. 1-6, pp. 1281–1287.
14. Ho E., Karimi Galougahi K., Liu C.C., Bhindi R., Figtree G.A. Biological Markers of Oxidative Stress: Applications to Cardiovascular Research and Practice. Redox Biol., 2013, vol. 1, no. 1, pp. 483–491. DOI: 10.1016/j.redox.2013.07.006
15. Strobel N.A., Fassett R.G., Marsh S.A., Coombes J.S. Oxidative Stress Biomarkers as Predictors of Cardiovascular Disease. Int. J. Cardiol., 2011, vol. 147, no. 2, pp. 191–201. DOI: 10.1016/j.ijcard.2010.08.008
16. Rochette L., Lorin J., Zeller M., Guilland J.C., Lorgis L., Cottin Y., Vergely C. Nitric Oxide Synthase Inhibition and Oxidative Stress in Cardiovascular Diseases: Possible Therapeutic Targets? Pharmacol. Ther., 2013, vol. 140, no. 3, pp. 239–257. DOI: 10.1016/j.pharmthera.2013.07.004